Prognostic Value of Endocan in Prostate Cancer: Clinicopathologic Association between Serum Endocan Levels and Biochemical Recurrence after Radical Prostatectomy

Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy

(2015) Yngve Nordby et al.   PROSTATE

Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining

(2015) DING MA et al.   Oncology Letters

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma

(2014) Kazuaki Ozaki et al.   Journal of Cancer

Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer

(2013) Manal M. El Behery et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A-Induced Angiogenesis

(2012) F. Roudnicky et al.   CANCER RESEARCH

Prognostic Factors for Failure after Prostatectomy

(2012) Gregory P. Swanson et al.   Journal of Cancer

Proteoglycans in cancer biology, tumour microenvironment and angiogenesis

(2010) Renato V. Iozzo et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma

(2009) Xavier Leroy et al.   HISTOPATHOLOGY

Endocan Expression and Localization in Human Glioblastomas

(2009) Claude-Alain Maurage et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer

(2009) Wilmer B. Roberts et al.   SURGICAL ONCOLOGY-OXFORD